Sterling Biotech group case accused Hitesh Patel detained in Albania
The Enforcement Directorate had ensued an Interpol red corner notice against him on March 11.
The Indian agencies will now seek Patel’s extradition, said people with direct knowledge of the matter. Patel is the brother-in-law of main accused, Nitin and Chetan Sandesara. The agency has so far attached assets worth Rs 4,700 crores.
The Sandesaras are currently hiding in Nigeria where they have invested in crude oil production.
ET was the first to report on October 12 that probe agencies are examining whether top government officials in the UPA-II regime and banks facilitated Vadodara-based Sterling Biotech, owned by the Sandesara family, to commit the fraud.

Although the Reserve Bank of India declared it a “wilful defaulter” in 2012, the Sandesara Group raised over $80 million (Rs 589 crore) from abroad, people with knowledge of the matter told ET.
ET was the first to report on October 25 that ED will move court seeking the tag of fugitive economic offender(s) against four accused in the Sterling Biotech case.
The agency has moved the court against Nitin Jayantilal Sandesara, Managing Director (MD) of Sterling Biotech; Nitin’s brother Chetan Sandesara, his wife Dipti Sandesara and Hitesh Patel.
ED has submitted details of the forensic audits conducted by State Bank of India and Andhra Bank, Mumbai, of companies formed by the Sandesaras. When the audit teams visited the addresses, they found a residential chawl, a slum rehabilitation centre and vacant buildings.
Also, “huge non-justified payments to directors (Sandesaras)” has been underlined in the 300-page charge sheet, exclusively accessed by ET. The agency claims to have recovered 10 lakh pages of documents and 200 digital devices during searches of the Sandesaras’s premises.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.